Revita hair loss shampoo, developed by DS Laboratories, is a cosmetic hair care product marketed to those experiencing hair thinning or early-stage hair loss. Available over the counter and online in the UK without a prescription, it is not a licensed medicinal treatment and is not regulated by the MHRA as a medicine. Formulated with a blend of ingredients including caffeine, biotin, and potentially ketoconazole, it aims to support scalp health and create conditions more favourable to hair growth. This article examines how Revita works, the evidence behind its key ingredients, how to use it safely, and when to seek professional medical advice.

What Is Revita Hair Loss Shampoo and How Does It Work?

Revita is a cosmetic shampoo by DS Laboratories designed to support scalp condition and reduce factors associated with hair thinning, such as oxidative stress and DHT sensitivity, but it is not MHRA-licensed to treat hair loss.

Not sure if this is normal? Chat with one of our pharmacists →

Revita Hair Loss Shampoo is a cosmetic hair care product developed by DS Laboratories, marketed towards individuals experiencing hair thinning or early-stage hair loss. It is sold as a hair-supporting shampoo rather than a licensed medicinal treatment. As a cosmetic product, it is not regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) as a medicine, and it is available over the counter and online in the UK without a prescription.

Note: the precise formulation sold in the UK may differ from versions available in other markets. Consumers should check the UK product label and ingredient list before use, as ingredient composition — including whether ketoconazole is present — can vary by region and may affect the product's regulatory classification.

Revita shampoo is formulated with a blend of cosmetic ingredients intended to support scalp condition and create an environment more conducive to healthy hair. Its proposed approach addresses several factors associated with hair thinning, including scalp oxidative stress and sensitivity to dihydrotestosterone (DHT), a derivative of testosterone widely recognised as a key driver of androgenetic alopecia (pattern hair loss) in both men and women. It is important to note, however, that as a cosmetic product, Revita is not licensed to treat, prevent, or cure any medical condition, and claims of DHT modulation should be understood in that context.

Revita shampoo is not a substitute for clinically proven, MHRA-licensed treatments for androgenetic alopecia. NICE CKS and NHS guidance on hair loss identifies topical minoxidil and, for adult men only, oral finasteride as evidence-based options — though it should be noted that finasteride is not routinely available on the NHS and is typically obtained privately. Revita may be considered as a complementary addition to an existing hair care routine, but individuals experiencing significant, sudden, or rapidly worsening hair loss should seek assessment from their GP or a dermatologist before relying on cosmetic products alone.

Key Ingredients and the Evidence Behind Them

Revita contains caffeine, biotin, ketoconazole (if present in the UK formulation), spin traps, and copper peptides, but evidence for these ingredients ranges from preclinical to low-certainty small studies with no large-scale RCT data for the combined formula.

Revita shampoo contains a proprietary blend of ingredients, each selected for a proposed role in scalp and follicle health. The following reflects the formulation as commonly described; consumers should verify the UK-specific INCI ingredient list on the product packaging, as regional formulations may differ.

• Ketoconazole (1%, if present in the UK formulation): An antifungal agent with some evidence of anti-androgenic properties at the scalp level. A small number of low-quality clinical trials have suggested modest improvements in hair density in androgenetic alopecia, though ketoconazole is not licensed for this indication in the UK. Its licensed use in topical form (e.g., ketoconazole 2% shampoo, as per the relevant MHRA-approved Summary of Product Characteristics) is for seborrhoeic dermatitis and dandruff. Claims that it meaningfully reduces scalp DHT levels in humans remain based on limited evidence and should be interpreted cautiously.

• Caffeine: In vitro (laboratory) research suggests caffeine may stimulate hair follicle activity and partially counteract DHT-related suppression of follicle growth. However, large-scale human clinical trials are lacking, and definitive conclusions cannot yet be drawn. This evidence should be considered preclinical.

• Biotin (Vitamin B7): Commonly included in hair care products for its role in keratin production. Evidence for benefit is primarily in individuals with confirmed biotin deficiency; there is little robust evidence that topical or supplemental biotin improves hair growth in those with normal levels.

• Spin Traps (e.g., DMPO): Included to neutralise free radicals on the scalp, theoretically reducing oxidative stress that may contribute to follicular damage. Human clinical data supporting this mechanism are very limited.

• Copper Peptides and Emu Oil: Proposed to support scalp condition and reduce inflammation. Robust clinical evidence in humans is limited, and these effects should be regarded as speculative at present.

Overall, whilst individual ingredients show early promise, the combined formulation has not been evaluated in large-scale, peer-reviewed randomised controlled trials. Evidence quality ranges from preclinical to low-certainty small studies. Consumers should approach efficacy claims with measured expectations and consult a healthcare professional for evidence-based hair loss management.

How to Use Revita Shampoo Safely and Effectively

Apply to wet hair, massage gently into the scalp, leave on for the time stated on the UK label, then rinse thoroughly; avoid use on broken or inflamed skin and consult a GP or midwife if pregnant or breastfeeding.

To maximise the potential benefits of Revita shampoo whilst minimising the risk of scalp irritation, always follow the instructions provided on the UK product label, as these take precedence over any general guidance. The following steps reflect typical usage as described by the manufacturer, but individual pack instructions may vary.

• Apply to wet hair and scalp: Dispense a small amount of shampoo and work it gently into the scalp using fingertips, not nails, to avoid mechanical irritation.

• Leave on for the time stated on the label: Unlike standard shampoos used purely for cleansing, Revita is designed to remain in contact with the scalp for a short period to allow active ingredients to act on the scalp surface.

• Rinse thoroughly: Ensure all product is fully removed to prevent residue build-up, which may contribute to scalp irritation in some individuals.

• Frequency of use: Follow the frequency stated on the UK pack. Daily use is generally not necessary and may increase the risk of scalp dryness or sensitivity in some individuals.

• Avoid contact with eyes: If contact occurs, rinse thoroughly with water. Discontinue use and seek pharmacist or GP advice if marked irritation develops.

For best results, Revita shampoo is often used as part of a broader hair care routine. If you are using other topical treatments — such as minoxidil solution — apply these after shampooing and drying the scalp, as directed by your prescriber or pharmacist. Do not use Revita on broken, inflamed, or infected scalp skin without first seeking medical advice. Pregnant or breastfeeding individuals should consult their GP or midwife before introducing new scalp products, particularly those containing ketoconazole, which is contraindicated in certain circumstances (refer to the product SmPC or seek pharmacist advice).

Potential Side Effects and Scalp Reactions to Be Aware Of

Common reactions include scalp dryness, mild itching, and redness; contact dermatitis, persistent inflammation, or sudden worsening hair loss require prompt pharmacist or GP assessment.

As with any cosmetic or topical product containing active ingredients, Revita shampoo carries a risk of adverse scalp reactions in some users. Most reactions are mild and localised, but it is important to recognise signs that warrant medical attention.

Commonly reported reactions may include:

• Scalp dryness or tightness, particularly with frequent use

• Mild itching or tingling during the initial weeks of use

• Redness or mild irritation at the hairline or scalp

Less common but more significant reactions to watch for:

• Persistent or worsening scalp inflammation

• Contact dermatitis — characterised by a rash, blistering, or intense itching — which may indicate an allergy to one or more ingredients; if this occurs, stop use and seek pharmacist or GP advice

• Unusual hair texture changes or increased breakage

Note: a temporary increase in hair shedding is a recognised phenomenon associated with certain licensed hair loss treatments (such as topical minoxidil), but it is not an established or expected response to cosmetic shampoo use. If you notice increased hair shedding after starting Revita, stop use and consult your GP or pharmacist rather than assuming it is a normal response.

Ketoconazole, if present in the UK formulation, can occasionally cause localised irritation or allergic contact dermatitis in sensitive individuals, consistent with its known adverse effect profile as described in the relevant MHRA-approved Summary of Product Characteristics.

Experiencing these side effects? Our pharmacists can help you navigate them →

When to seek medical advice — including urgent or prompt assessment:

• If scalp symptoms persist beyond two to four weeks of use

• If you notice sudden, patchy, or rapidly worsening hair loss — this may indicate an underlying medical condition such as alopecia areata, thyroid dysfunction, iron deficiency, or other systemic cause requiring investigation

• If you develop signs of a painful, inflamed, or scarring scalp — including pustules, boggy or tender areas, or permanent-looking hair loss — seek prompt GP assessment, as these may indicate scarring (cicatricial) alopecia or another condition requiring specialist dermatology review

• In children or adolescents with patchy hair loss accompanied by scalp scaling, 'black dots', or lymph node swelling, tinea capitis (scalp ringworm) should be considered and assessed by a GP promptly

• If you develop signs of a severe allergic reaction — including facial swelling, urticaria, or difficulty breathing — call 999 immediately

Always inform your GP of any over-the-counter products you are using, particularly if you are undergoing treatment for a scalp condition or taking systemic medications. If you suspect a side effect from this product, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions